The largest community of pharma leaders

Be part of our community by subscribing to our newsletters! Follow the steps below.

1. Subscribe to our Announcement Newsletter. You will receive our news about what do you kneed to know about our work and the resources available for you. 

2. Choose your favorite writer. We constantly look for the top minds on the pharmaceutical marketing industry. You can subscribe to their article on their pages and receive every article on your inbox. 

3. Choose the Newsletter that better fits you needs. We recommend the Editor’s pick to receive everything you need to know in one weekly email. 

You can start here by subscribing to our main Newsletter

NEWSLETTER ANNOUCEMENTS




TPMG FEATURED WRITER NEWSLETTER




Secondary effects of COVID-19 on the healthcare system and...

A version of this article was previously published on Pharmaphorum. By now, your social media feeds are probably full...

“Go-to-Market”: Medical Affairs, Strategies and Timings

“Go-to-Market” in Pharma is defined as a tactical action plan, that outlines the needed steps to succeed in a...

Working with, Advocating for, and Empowering Patients

A version of this article was previously published on Pharmaphorum. In recent years, there has been a clear shift in...

Medical Affairs and Stakeholder Engagement in an Evolving Healthcare...

Due to unprecedented challenging situation and the current pandemic time, stakeholders needs are changing and these uncertain times are...

“Fake News” and Credibility in Medical Publishing

A version of this article was previously published on Pharmaphorum. Doubtlessly, one of the defining phrases of the 2010s is...

Top 10 Most Important Advisor Questions

Today, I would like to share the top 10 most important advisor questions that every brand team should keep in mind...

Optimizing Survivorship Care in Oncology

I have previously discussed a range of topics related to the diagnosis and treatment of cancer, including the use...

Navigating Emerging Markets – Opportunities and Challenges for Pharma

The pharmaceutical industry is quickly evolving; to stay relevant and competitive, companies need to stay on top of the...

Natalie Yeadon´s Newsletter




Secondary effects of COVID-19 on the healthcare system and...

A version of this article was previously published on Pharmaphorum. By now, your social media feeds are probably full...

Working with, Advocating for, and Empowering Patients

A version of this article was previously published on Pharmaphorum. In recent years, there has been a clear shift in...

“Fake News” and Credibility in Medical Publishing

A version of this article was previously published on Pharmaphorum. Doubtlessly, one of the defining phrases of the 2010s is...

Top 10 Most Important Advisor Questions

Today, I would like to share the top 10 most important advisor questions that every brand team should keep in mind...

Optimizing Survivorship Care in Oncology

I have previously discussed a range of topics related to the diagnosis and treatment of cancer, including the use...

Navigating Emerging Markets – Opportunities and Challenges for Pharma

The pharmaceutical industry is quickly evolving; to stay relevant and competitive, companies need to stay on top of the...

Tommaso Salanitri´s Newsletter




“Go-to-Market”: Medical Affairs, Strategies and Timings

“Go-to-Market” in Pharma is defined as a tactical action plan, that outlines the needed steps to succeed in a...

Medical Affairs and Stakeholder Engagement in an Evolving Healthcare...

Due to unprecedented challenging situation and the current pandemic time, stakeholders needs are changing and these uncertain times are...

EDITOR´S PICK




U.S. Food and Drug Administration Approves Gilead’s Antiviral Veklury®...

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the U.S. Food and Drug Administration (FDA) has...

Gilead Sciences Completes Acquisition of Immunomedics, Inc.

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced the completion of the previously announced transaction to acquire...

Arixa Pharmaceuticals Announces Acquisition by Pfizer’s Hospital Business

PALO ALTO, Calif.--(BUSINESS WIRE)--Arixa Pharmaceuticals™, Inc., a company dedicated to developing next-generation oral antibiotics for drug-resistant Gram-negative infections today...

Moderna Completes Enrollment of Phase 3 COVE Study of...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Moderna, Inc., (Nasdaq: MRNA) a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a...

Feinstein Institutes researchers find effective COVID-19 ‘cytokine storm’ treatment

MANHASSET, N.Y.--(BUSINESS WIRE)--Some immune systems have responded to coronavirus disease 2019 (COVID-19) infections by going into overdrive, resulting in...

AppliedVR Receives FDA Breakthrough Device Designation to Treat Pain...

LOS ANGELES--(BUSINESS WIRE)--AppliedVR, a pioneer advancing the next generation of digital medicine, today announced its EaseVRx product received Breakthrough...

LOOK WHO IS ON THE MOVE!




Anthony Welters Joins Gilead Sciences’ Board of Directors

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) announced today that Anthony Welters has been appointed to the company’s...

AVIA Names Linda Finkel as CEO

CHICAGO--(BUSINESS WIRE)--AVIA, the nation’s leading digital transformation partner for healthcare organizations, announced that its board of directors has appointed...

SQZ Biotech Strengthens Board of Directors and Appoints New...

WATERTOWN, Mass.--(BUSINESS WIRE)--SQZ Biotechnologies (SQZ), a clinical-stage biotechnology company developing transformative cell therapies for patients with cancer, infectious diseases...

AVIA Names Linda Finkel as CEO

CHICAGO--(BUSINESS WIRE)--AVIA, the nation’s leading digital transformation partner for healthcare organizations, announced that its board of directors has appointed...

SQZ Biotech Strengthens Board of Directors and Appoints New...

WATERTOWN, Mass.--(BUSINESS WIRE)--SQZ Biotechnologies (SQZ), a clinical-stage biotechnology company developing transformative cell therapies for patients with cancer, infectious diseases...

SQZ Biotech Strengthens Board of Directors and Appoints New...

WATERTOWN, Mass.--(BUSINESS WIRE)--SQZ Biotechnologies (SQZ), a clinical-stage biotechnology company developing transformative cell therapies for patients with cancer, infectious diseases...

INDUSTRY NEWS




Reven Pharmaceuticals Reports on the Importance of Micronutrients and...

GOLDEN, Colo.--(BUSINESS WIRE)--Reven Holdings, Inc. (“Reven”), a privately held clinical stage biotechnology and pharmaceutical company dedicated to the discovery...

Bayer’s FIDELIO-DKD Phase III Study Demonstrated Investigational Drug Finerenone...

WHIPPANY, N.J.--(BUSINESS WIRE)--Bayer announced today that detailed results from the FIDELIO-DKD Phase III study demonstrated that the investigational drug...

Gilead Sciences Completes Acquisition of Immunomedics, Inc.

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced the completion of the previously announced transaction to acquire...

Aerogen Collaborates on Development of More Than 15 Potential...

GALWAY, Ireland--(BUSINESS WIRE)--Aerogen, the global leader in aerosol drug delivery, today announced details of a broad collaborative effort to...

Aerogen Collaborates on Development of More Than 15 Potential...

GALWAY, Ireland--(BUSINESS WIRE)--Aerogen, the global leader in aerosol drug delivery, today announced details of a broad collaborative effort to...

FARXIGA DAPA-CKD Phase III Trial Reduced Worsening of Kidney...

WILMINGTON, Del.--(BUSINESS WIRE)--A new subgroup analysis from the ground-breaking DAPA-CKD Phase III trial showed that AstraZeneca’s FARXIGA® (dapagliflozin), on...

REGULATORY AFFAIRS




Kezar Life Sciences Announces Orphan Drug Designations for KZR-616...

SAN FRANCISCO--(BUSINESS WIRE)--Kezar Life Sciences, Inc. (Nasdaq: KZR), a clinical-stage biotechnology company discovering and developing breakthrough treatments for immune-mediated...

FARXIGA DAPA-CKD Phase III Trial Reduced Worsening of Kidney...

WILMINGTON, Del.--(BUSINESS WIRE)--A new subgroup analysis from the ground-breaking DAPA-CKD Phase III trial showed that AstraZeneca’s FARXIGA® (dapagliflozin), on...

Reven Pharmaceuticals Wins FDA Approval of Its IND Application...

GOLDEN, Colo.--(BUSINESS WIRE)--Reven Holdings, Inc. (“Reven”) is a privately held clinical stage biotechnology and pharmaceutical company dedicated to the...

Cala Health Receives FDA Breakthrough Device Designation for Cala...

BURLINGAME, Calif.--(BUSINESS WIRE)--Cala Health, Inc., a bioelectronic medicine company developing wearable therapies for chronic disease, announced that the U.S....

LEO Pharma Announces U.S. FDA Approval for Enstilar® (calcipotriene...

BALLERUP, Denmark & MADISON, N.J.--(BUSINESS WIRE)--LEO Pharma A/S today announced the U.S. Food and Drug Administration (FDA) has approved...

Adaptive Phage Therapeutics Receives Orphan Drug Designation for PhageBank™...

GAITHERSBURG, Md.--(BUSINESS WIRE)--Adaptive Phage Therapeutics (APT), a clinical-stage biotechnology company dedicated to providing therapies to treat the global rise...

MEDICAL DEVICES




Remote Medical International Partners With 1health.io to Provide COVID-19...

SAN FRANCISCO--(BUSINESS WIRE)--Remote Medical International, the company providing workplace health and safety services for Fortune 100 corporations, today announced...

Astrotech Subsidiary and Cleveland Clinic Partner to Develop a...

AUSTIN, Texas & CLEVELAND--(BUSINESS WIRE)--Astrotech Corporation’s (NASDAQ: ASTC) subsidiary, BreathTech Corporation announced today that it has signed a joint...

O2 Industries Launches the TR2, a Tactical Respirator for...

TORONTO--(BUSINESS WIRE)--O2 Industries, a leading manufacturer of reusable respirators since 2014, today announces the release of the Tactical Respirator...

First Databank Announces Partnership with RxCap for Medication Adherence...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--First Databank, Inc. (FDB), the leading provider of drug and medical device knowledge that helps...

PerkinElmer Immunoassay Helps NIH NCATS Team Identify Therapeutic Compounds...

WALTHAM, Mass.--(BUSINESS WIRE)--PerkinElmer, Inc. (NYSE:PKI), a global leader committed to innovating for a healthier world, today announced that a...

SG Blocks and OSANG Healthcare Announce Managed Supply Agreement...

NEW YORK--(BUSINESS WIRE)--SG Blocks, Inc. (Nasdaq: SGBX) ("SG Blocks" or the "Company"), a leader in modular container-based structures and...

HOSPITAL NEWS




Reven Pharmaceuticals Reports on the Importance of Micronutrients and...

GOLDEN, Colo.--(BUSINESS WIRE)--Reven Holdings, Inc. (“Reven”), a privately held clinical stage biotechnology and pharmaceutical company dedicated to the discovery...

Anthony Welters Joins Gilead Sciences’ Board of Directors

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) announced today that Anthony Welters has been appointed to the company’s...

AVIA Names Linda Finkel as CEO

CHICAGO--(BUSINESS WIRE)--AVIA, the nation’s leading digital transformation partner for healthcare organizations, announced that its board of directors has appointed...

Goldfinch Bio Presents Clinical Data from Phase 1 Trial...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Goldfinch Bio, a clinical stage biotechnology company focused on discovering and developing precision medicines for the treatment...

U.S. Food and Drug Administration Approves Gilead’s Antiviral Veklury®...

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the U.S. Food and Drug Administration (FDA) has...

Kezar Life Sciences Announces Orphan Drug Designations for KZR-616...

SAN FRANCISCO--(BUSINESS WIRE)--Kezar Life Sciences, Inc. (Nasdaq: KZR), a clinical-stage biotechnology company discovering and developing breakthrough treatments for immune-mediated...

BIOTECHNOLOGY




Goldfinch Bio Presents Clinical Data from Phase 1 Trial...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Goldfinch Bio, a clinical stage biotechnology company focused on discovering and developing precision medicines for the treatment...

Confo Therapeutics Announces Selection of First Product Candidate and...

GHENT, Belgium--(BUSINESS WIRE)--Confo Therapeutics today announced the selection of its first preclinical drug candidate, CFTX-1554, a compound designed to...

Transgene and BioInvent to Present Data on Oncolytic Virus...

STRASBOURG, France & LUND, Sweden--(BUSINESS WIRE)--Regulatory News: Transgene (Paris:TNG) (Euronext Paris: TNG), a biotech company that designs and develops virus-based...

BryoLogyx Announces Completion of World’s First GMP Synthesis of...

DANVILLE, Calif.--(BUSINESS WIRE)--BryoLogyx, Inc., today announced that it has completed the synthesis of bryostatin-1 molecule, pursuant to FDA’s Good...

Goldfinch Bio Announces Upcoming Presentation of Phase 1 Clinical...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Goldfinch Bio, a clinical stage biotechnology company focused on discovering and developing precision medicines for the treatment...

Twist Bioscience and Neogene Announce Broad Strategic Partnership for...

SOUTH SAN FRANCISCO, Calif. & AMSTERDAM & NEW YORK--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to...